1 day Ago By ABMN Staff
Marshall Wace LLP purchased a new position in shares of Abacus Life, Inc. ( NASDAQ:ABL – Free Report ) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 165,090 shares of the company’s stock, valued at approximately $1,293,000.
Marshall Wace LLP owned 0.17% of Abacus Life at the end of the most recent quarter. A number of other hedge funds have also modified their holdings of the business.
XTX Topco Ltd purchased a new position in shares of Abacus Life during the 4th quarter worth $193,000. Kennedy Capital Management LLC purchased a new position in Abacus Life during the 4th quarter valued at about $7,461,000. Renaissance Technologies LLC boosted its holdings in Abacus Life by 356.
0% during the 4th quarter. Renaissance Technologies LLC now owns 210,500 shares of the company’s stock valued at $1,648,000 after acquiring an additional 164,334 shares during the period. Foundry Partners LLC purchased a new position in Abacus Life during the 4th quarter valued at about $5,364,000.
Finally, Discovery Capital Management LLC CT purchased a new position in Abacus Life during the 4th quarter valued at about $1,958,000. Analyst Upgrades and Downgrades ABL has been the subject of a number of research analyst reports. B.
Riley lowered their target price on Abacus Life from $17.00 to $15.00 and set a “buy” rating for the company in a report on Tuesday, January 7th.
Piper Sandler lowered their target price on Abacus Life from $13.00 to $11.50 and set an “overweight” rating for the company in a report on Tuesday, April 8th.
Finally, Maxim Group assumed coverage on Abacus Life in a report on Tuesday. They set a “buy” rating and a $14.00 target price for the company.
Six analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $14.
00. Abacus Life Trading Down 0.5 % Shares of Abacus Life stock opened at $8.
20 on Wednesday. The company has a fifty day simple moving average of $7.61 and a 200-day simple moving average of $7.
92. Abacus Life, Inc. has a 12-month low of $6.
34 and a 12-month high of $12.40. The company has a current ratio of 1.
29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65.
The stock has a market cap of $794.19 million, a price-to-earnings ratio of -45.55 and a beta of 0.
16. Abacus Life ( NASDAQ:ABL – Get Free Report ) last issued its earnings results on Thursday, March 27th. The company reported $0.
16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.03.
The business had revenue of $33.21 million during the quarter, compared to analysts’ expectations of $28.76 million.
Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%.
On average, equities analysts forecast that Abacus Life, Inc. will post 0.62 EPS for the current fiscal year.
Abacus Life Company Profile ( Free Report ) Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Further Reading Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter ..
